var szzbAffiches=[["01099","finalpage/2018-10-29/1205550640.PDF","国药控股：公告","PDF","330","2018-10-29","2018-10-29 08:00"],["01057","finalpage/2018-10-29/1205550636.PDF","浙江世宝：内幕消息 - 2018年第三季度报告","PDF","909","2018-10-29","2018-10-29 07:52"],["00223","finalpage/2018-10-29/1205550637.PDF","易生活控股：有关董事根据特别授权认购新股份之关连交易","PDF","266","2018-10-29","2018-10-29 07:52"],["01809","finalpage/2018-10-29/1205550634.PDF","浦林成山：稳定价格期间结束、稳定价格行动及超额配股权告失效","PDF","166","2018-10-29","2018-10-29 07:49"],["01070","finalpage/2018-10-29/1205550632.PDF","TCL电子：截至二零一八年九月三十日止九个月及三个月之业务进展公告","PDF","239","2018-10-29","2018-10-29 07:48"],["01057","finalpage/2018-10-29/1205550633.PDF","浙江世宝：海外监管公告","PDF","933","2018-10-29","2018-10-29 07:48"],["01057","finalpage/2018-10-29/1205550631.PDF","浙江世宝：海外监管公告","PDF","634","2018-10-29","2018-10-29 07:48"],["01928","finalpage/2018-10-29/1205550630.PDF","金沙中国有限公司：内幕消息-本公司控股股东LAS VEGAS SANDS CORP.,截至二零一八年九月三十日止第三个财政季度业绩10-Q表季度报告","PDF","558","2018-10-29","2018-10-29 07:42"],["01339","finalpage/2018-10-29/1205550629.PDF","中国人民保险集团：海外监管公告 - A股发行安排及初步询价公告","PDF","1198","2018-10-29","2018-10-29 07:42"],["01339","finalpage/2018-10-29/1205550627.PDF","中国人民保险集团：海外监管公告 - 招股意向书摘要","PDF","3862","2018-10-29","2018-10-29 07:42"],["01057","finalpage/2018-10-29/1205550628.PDF","浙江世宝：海外监管公告","PDF","577","2018-10-29","2018-10-29 07:42"],["01339","finalpage/2018-10-29/1205550625.PDF","中国人民保险集团：海外监管公告 - 招股意向书附录（四）","PDF","3288","2018-10-29","2018-10-29 07:38"],["01339","finalpage/2018-10-29/1205550623.PDF","中国人民保险集团：海外监管公告 - 招股意向书附录（三）","PDF","11869","2018-10-29","2018-10-29 07:38"],["01339","finalpage/2018-10-29/1205550621.PDF","中国人民保险集团：海外监管公告 - 招股意向书附录（二）","PDF","12785","2018-10-29","2018-10-29 07:38"],["01339","finalpage/2018-10-29/1205550620.PDF","中国人民保险集团：海外监管公告 - 招股意向书附录（一）","PDF","2885","2018-10-29","2018-10-29 07:38"],["01339","finalpage/2018-10-29/1205550619.PDF","中国人民保险集团：海外监管公告 - 招股意向书","PDF","14056","2018-10-29","2018-10-29 07:38"],["01061","finalpage/2018-10-29/1205550622.PDF","亿胜生物科技：内幕消息有关共同开发协议之最新消息有关乾眼症之美国药监局第一阶段三期临床试验","PDF","130","2018-10-29","2018-10-29 07:38"],["01057","finalpage/2018-10-29/1205550624.PDF","浙江世宝：海外监管公告","PDF","574","2018-10-29","2018-10-29 07:38"],["01339","finalpage/2018-10-29/1205550617.PDF","中国人民保险集团：公告 - 有关A股招股意向书的财务资料","PDF","211","2018-10-29","2018-10-29 07:38"],["01339","finalpage/2018-10-29/1205550616.PDF","中国人民保险集团：公告 - A股发行的初步询价期及A股招股意向书主要条文概要","PDF","205","2018-10-29","2018-10-29 07:38"],["01096","finalpage/2018-10-29/1205550618.PDF","中能国际控股：有关可换股债券之内幕消息","PDF","142","2018-10-29","2018-10-29 07:38"],["01034","finalpage/2018-10-29/1205550615.PDF","富汇建筑控股：董事名单与其角色和职能","PDF","79","2018-10-29","2018-10-29 07:38"],["01034","finalpage/2018-10-29/1205550614.PDF","富汇建筑控股：提名委员会职权范围","PDF","239","2018-10-29","2018-10-29 07:38"],["01034","finalpage/2018-10-29/1205550613.PDF","富汇建筑控股：薪酬委员会职权范围","PDF","252","2018-10-29","2018-10-29 07:38"],["01034","finalpage/2018-10-29/1205550612.PDF","富汇建筑控股：审核委员会职权范围","PDF","311","2018-10-29","2018-10-29 07:38"],["01034","finalpage/2018-10-29/1205550611.PDF","富汇建筑控股：经修订及重订之组织章程大纲及章程细则","PDF","1167","2018-10-29","2018-10-29 07:38"],["01889","finalpage/2018-10-29/1205550603.PDF","三爱健康集团：澄清公告","PDF","174","2018-10-29","2018-10-29 07:38"],["01116","finalpage/2018-10-29/1205550604.PDF","MAYER HOLDINGS：额外申请表格","PDF","380","2018-10-29","2018-10-29 07:38"],["01116","finalpage/2018-10-29/1205550602.PDF","MAYER HOLDINGS：申请表格","PDF","326","2018-10-29","2018-10-29 07:38"],["01034","finalpage/2018-10-29/1205550610.PDF","富汇建筑控股：发售价及分配结果公告","PDF","188","2018-10-29","2018-10-29 07:38"],["01034","finalpage/2018-10-29/1205550609.PDF","富汇建筑控股：发售价及分配结果公告","PDF","1123","2018-10-29","2018-10-29 07:38"],["01034","finalpage/2018-10-29/1205550608.PDF","富汇建筑控股：发售价及分配结果公告","PDF","177","2018-10-29","2018-10-29 07:38"],["01034","finalpage/2018-10-29/1205550607.PDF","富汇建筑控股：发售价及分配结果公告","PDF","166","2018-10-29","2018-10-29 07:38"],["01034","finalpage/2018-10-29/1205550606.PDF","富汇建筑控股：发售价及分配结果公告","PDF","197","2018-10-29","2018-10-29 07:38"],["01034","finalpage/2018-10-29/1205550605.PDF","富汇建筑控股：发售价及分配结果公告","PDF","702","2018-10-29","2018-10-29 07:38"],["01116","finalpage/2018-10-29/1205550601.PDF","MAYER HOLDINGS：按於记录日期每持有一(1) 股经调整股份获发四(4) 股发售股份之基准按每股发售股份0.20 港元公开发售1,398,400,000 股发售股份","PDF","786","2018-10-29","2018-10-29 07:38"]];
